Previously, genistein has been reported to inhibit the growth of lung cancer by downregulating essential oncoproteins, phosphorylated AKT (pAKT), and phosphorylated phosphoinositide-3 kinase (p-PI3K) (7). This evidence concerns the gene AKT1 and lung carcinoma.